This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
broker-rating: Archive
Is Block (SQ) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Block (SQ). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
SQPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Ares Capital (ARCC): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Ares Capital (ARCC). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
ARCCNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Rio Tinto (RIO) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Rio Tinto (RIO). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
RIOPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Toyota Motor (TM) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Toyota Motor (TM). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
TMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Rivian Automotive (RIVN) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Rivian Automotive (RIVN). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
RIVNPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Seanergy Maritime Holdings (SHIP) Based on Bullish Wall Street Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Seanergy Maritime Holdings (SHIP) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SHIPPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Bank of America (BAC) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Bank of America (BAC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
BACPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Citigroup (C) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Citigroup (C). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
CPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Vistra (VST) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Vistra (VST). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
VSTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Cameco (CCJ) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Cameco (CCJ). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
CCJPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Broadcom Inc. (AVGO) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Broadcom Inc. (AVGO) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
AVGOPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in Synchronoss (SNCR) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Synchronoss (SNCR) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SNCRPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Abercrombie (ANF) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Abercrombie (ANF) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
ANFPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think PepsiCo (PEP) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for PepsiCo (PEP) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
PEPNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is Ardmore Shipping (ASC) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Ardmore Shipping (ASC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
ASCPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in Royal Caribbean (RCL): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for Royal Caribbean (RCL) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
RCLNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in JD.com (JD): Read This Before Placing a Bet
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), JD.com (JD) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
JDNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Should You Invest in Commvault (CVLT) Based on Bullish Wall Street Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Commvault (CVLT) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
CVLTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts See Lululemon (LULU) as a Buy: Should You Invest?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Lululemon (LULU). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
LULUPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Brokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet
by Zacks Equity Research
The average brokerage recommendation (ABR) for CVS Health (CVS) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
CVSNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Superior Group (SGC) Is a Good Investment: Is It?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Superior Group (SGC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
SGCNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think Leidos (LDOS) Is a Good Investment: Is It?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Leidos (LDOS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
LDOSNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Is It Worth Investing in SYMBOTIC INC (SYM) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for SYMBOTIC INC (SYM) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
SYMPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth
Wall Street Analysts Think UnitedHealth (UNH) Is a Good Investment: Is It?
by Zacks Equity Research
The average brokerage recommendation (ABR) for UnitedHealth (UNH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
UNHNegative Net Change
broker-rating earnings-estimates-revisions earnings-growth
Ouster (OUST) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for Ouster (OUST) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
OUSTPositive Net Change
broker-rating earnings-estimates-revisions earnings-growth